ALL KEYWORDS
Breast Cancer Chemotherapy
Related Specialists
Showing 3 of 38
Related Fact Sheets
Related Clinical Trials
Showing 2 of 7
Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
- Breast Cancer
Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone for MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer
- Breast Cancer
Related Departments
Showing 3 of 51